Sponsor:
SHY Therapeutics
Code:
NCT07705334
Conditions
Advanced or Metastatic Solid Tumors
Triple Negative Breast Cancer (TNBC)
HR+ Breast Cancer
Colon Cancer
Gastric Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SHY-ONC6
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-12. This information was provided to ClinicalTrials.gov by SHY Therapeutics on 2026-08-10.